Specialty × MAC Jurisdiction Intelligence
RheumatologyCMS & MAC AlertsPalmetto GBA · Jurisdictions JJ, JM
Every CMS transmittal, Palmetto GBA LCD revision, Federal Register notice, and OIG alert affecting Rheumatology billing teams in Georgia, North Carolina, South Carolina, Tennessee, Virginia, West Virginia. Signal-scored and updated daily.
Active alerts
11
Critical / High
4
MAC jurisdiction
JJ, JM
Highest-risk CPT
CPT 99214
Recent Rheumatology alerts under Palmetto GBA
4 of the 11 most recent Rheumatology reimbursement alerts are Critical/High-severity for Palmetto GBA (Jurisdictions JJ, JM) billing teams. Each links to the source CMS/MAC document with the codes to review and the action to take.
- FDA Approval: XELJANZ (TOFACITINIB) — Type 1 - New Molecular EntityJul 8, 2026
- FDA Approval: XELJANZ XR (TOFACITINIB) — Type 3 - New Dosage FormJul 8, 2026
- FDA Approval: RINVOQ (UPADACITINIB) — Type 1 - New Molecular EntityJul 8, 2026
- FDA Approval: XELJANZ (TOFACITINIB) — Type 3 - New Dosage FormJul 8, 2026
- FDA Approval: OLUMIANT (BARICITINIB) — Type 1 - New Molecular EntityJul 8, 2026
- FDA Approval: RINVOQ (UPADACITINIB) — Type 3 - New Dosage FormJul 8, 2026
- FDA Approval: EXDENSUR (DEPEMOKIMAB) — Type 1 - New Molecular EntityJun 13, 2026
- LCD L39427: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — CGSCGS Administrators · Jun 5, 2026
- LCD L39481: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — WPSWPS · Jun 5, 2026
- LCD L39467: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — NoridianNoridian · Jun 5, 2026
- LCD L39469: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis — NoridianNoridian · Jun 5, 2026
Signal intelligence — Rheumatology × Palmetto GBA
Highest-risk CPT code
CPT 99214
Office visit, established patient, moderate complexity
View full CPT alert profilePalmetto GBA jurisdiction
JJ, JM
Covers Georgia, North Carolina, South Carolina, Tennessee, Virginia, West Virginia. Every rheumatology LCD revision, CMS transmittal, and Federal Register notice affecting these states is signal-scored and surfaced here daily.
View all 11 active alerts for Rheumatology under Palmetto GBA
Full alert text, action recommendations, effective date deadlines, MAC LCD links, and signal score rationale — updated daily.
About Palmetto GBA (Jurisdictions JJ, JM)
Palmetto GBA is the Medicare Administrative Contractor responsible for processing Medicare Part A and Part B claims in Jurisdictions JJ, JM, covering Georgia, North Carolina, South Carolina, Tennessee, Virginia, West Virginia.Palmetto GBA issues Local Coverage Determinations (LCDs) that define coverage criteria, ICD-10-CM diagnosis code requirements, and CPT billing guidelines for Rheumatology procedures within its jurisdiction. CLV Intelligence monitors Palmetto GBA's LCD publication feed, provider bulletin archives, and CMS contractor-specific transmittals daily.
Rheumatology alerts in other MAC jurisdictions
Get weekly Rheumatology alerts for Palmetto GBA — free
No credit card required. Unsubscribe any time.